Oura prices its IPO this coming week, and the headline figure is striking: 50 million shares at $40 to $44, targeting up to $2.2 billion in proceeds, with 73% of the deal classified as secondary. That last number is the one that deserves your full attention before you decide whether to participate.
The offering consists of 13.5 million shares issued by Oura itself and 36.5 million shares sold by existing shareholders, from which the company will receive no proceeds. Insiders cashing 36.5 million shares at $44 collect roughly $1.6 billion. Oura’s own balance sheet sees only the primary slice. Those insiders are exiting at a valuation roughly 40% to 45% above the company’s reported Series E valuation in October 2025. That is a clean and legal outcome for early backers. It is also worth naming clearly when evaluating the opportunity on its merits.
What the Business Actually Looks Like
The underlying financials are not the problem. Membership revenue grew 121% year over year to $240.5 million for the nine months ended June 30, 2026, and the company reported $60.9 million in net income for that nine-month period. As of June 30, 2026, Oura served 5.0 million paid members, up 100% year over year, with weighted-average 12-month paid member retention of approximately 85%. Retention at 85% for a $5.99 monthly subscription is a meaningful signal that the product earns its keep after the hardware sale.
Oura’s filings cite IDC estimates for the overall wearables market, but they do not support the claim that IDC puts Oura’s share of the global smart ring market above 80%, nor the device-shipments breakdown stated here. Oura is clearly an early category leader, but investors should treat precise smart ring share figures with caution unless independently sourced.
Cornerstone investors Eli Lilly and Dragoneer Investment Group have indicated interest in up to $400 million of the IPO, representing about 19% of the deal at the midpoint. Eli Lilly’s involvement is not merely financial: it has indicated interest in buying up to $100 million of shares, and Dragoneer has indicated interest in buying up to $300 million, both at the IPO price and on the same terms as other purchasers. A pharmaceutical anchor can signal something more durable than consumer excitement.
The Valuation Question
At $40 to $44 per share, Oura is targeting an initial market capitalization of around $12.8 billion to $14.1 billion, representing approximately $15.6 billion on a fully diluted basis. Against $240.5 million in membership revenue growing at triple digits, that is a rich multiple. Even including total revenue, Oura booked $1.4 billion for the twelve months ended June 30, 2026, which puts the fully diluted valuation at roughly 11 times trailing revenue. That is not an absurd number for a fast-growing, profitable subscription platform, but it leaves no room for execution stumbles in the first year as a public company.
The competitive landscape worth watching is not Apple or Garmin directly, but what happens when Samsung spends to scale Galaxy Ring and Whoop eventually tests its own private valuation in public markets. Oura’s 85% retention argues the product is genuinely useful. The question is whether that moat holds at scale when rivals start competing on price.
How to Think About It as a Wealth-Building Decision
For long-term investors, the honest framework here is patience. Cautious investors may prefer to wait for post-listing volatility to subside before establishing a position, and that instinct is sensible when 73% of the offering is sellers who have already decided what the stock is worth to them. IPO-day price discovery with that much secondary supply can cut both ways.
If the subscription growth rate holds anywhere near 100% through fiscal 2027, the current valuation becomes easier to justify. If growth decelerates sharply as the paid member base matures past 5 million, $13 billion looks expensive fast. Watch whether membership revenue momentum stays strong and whether retention remains near 85% as the first post-IPO quarters arrive. Those numbers will tell you more than the opening trade.
Today’s takeaway: A company can have genuinely strong fundamentals and still present a complicated entry point when most of the offering is insiders selling. Oura’s subscription business is real. The price you pay for it next week needs to account for the sellers on the other side of your trade.
